Form 8-K - Current report:
SEC Accession No. 0000950123-06-008655
Filing Date
2006-07-06
Accepted
2006-07-06 16:35:12
Documents
5
Period of Report
2006-06-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y22994e8vk.htm 8-K 14106
2 EX-10.1: STOCK INCENTIVE PLAN FOR NEW HIRES y22994exv10w1.htm EX-10.1 28808
3 EX-99.1: PRESS RELEASE y22994exv99w1.htm EX-99.1 18745
4 GRAPHIC y22994y2299400.gif GRAPHIC 3563
5 GRAPHIC y22994y2299401.gif GRAPHIC 3819
  Complete submission text file 0000950123-06-008655.txt   73764
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 06948425
SIC: 2835 In Vitro & In Vivo Diagnostic Substances